Abstract TMP88: Impact of Tandem Vertebrobasilar Occlusion on Outcome of Mechanical Thrombectomy for Basilar Artery Occlusion
Conor Cunningham,Sameh Samir Elawady,Hidetoshi Matsukawa,Noah Lee Nawabi,Mohammad-Mahdi Sowlat,Sara Zandpazandi,Kazutaka Uchida,Atakan Orscelik,Ilko Maier,Sami Al Kasab,Pascal M Jabbour,Joon-Tae Kim,Stacey C Quintero,ansaar rai,Robert Starke,Marios Psychogios,Amir Shaban,Adam S Arthur,Shinichi Yoshimura,Hugo Cuellar,Jonathan A Grossberg,Ali M Alawieh,Daniele G. Romano,Omar Tanweer,Justin Mascitelli,Isabel Fragata,Adam Polifka,Joshua Osbun,Roberto Crosa,Charles C Matouk,Min S Park,Michael Levitt,Waleed Brinjikji,Mark Moss,Travis Dumont,Richard Williamson,Pedro Navia,Peter Kan,Reade A De Leacy,Shakeel A Chowdhry,Mohamad Ezzeldin,Alejandro M Spiotta
DOI: https://doi.org/10.1161/str.55.suppl_1.tmp88
IF: 10.17
2024-02-01
Stroke
Abstract:Introduction: The efficacy of mechanical thrombectomy (MT) for tandem vertebrobasilar occlusion (tVBO) is not well established in patients with basilar artery occlusion (BAO). Objective: To investigate the treatment outcomes of MT in tVBO. Method: This international, multicenter, retrospective cohort included patients with MT for tVBO and isolated BAO from 2013 to 2023. The primary outcome was the 90-day modified Rankin Scale (mRS) score 0-2. Secondary outcomes included complete recanalization (modified Thrombolysis in Cerebral Ischemia [mTICI] ≥ 2C) and 90-day mortality rate. These outcomes were compared between tVBO and isolated BAO groups. Adjustment factors were age, sex, admission National Institutes of Health Stroke Scale (NIHSS), pre-morbid mRS, onset to groin duration, and intravenous tissue plasminogen activator. Results: Among 10,229 patients, 689 had BAO. Of those, 61 (9.7%) had a tVBO. Median age was 61 [IQR 53-74] years and 29 (47.5%) patients were female. Compared to isolated BAO, tVBO group had lower age (61 [53-74] versus 68 [58-79], P<0.001) and lower admission NIHSS (15 [7 - 22] versus 17 [9-26], P≤0.05). There was no significant difference in the rate of complete recanalization between the two groups (adjusted odds ratio [aOR]: 0.83; 95% CI: 0.39-1.79; P=0.60) However, the tVBO group had significantly lower odds of a favorable outcome compared to the isolated BAO group (aOR: 0.35; 95% CI: 0.13-0.83; P=0.023) and higher odds of 90-day mortality (aOR: 3.51; 95% CI: 1.59-7.85; P=0.002). Binary regression analysis revealed that age (OR 0.98; 95% CI 0.96 - 1.00; P=0.019), admission NIHSS (OR 0.90; 95% CI 0.87-0.93; P<0.001), premorbid mRS (OR 0.71; 95% CI 0.53-0.93; P=0.016), successful recanalization (OR 2.94; 95% CI 1.71-5.15; P<0.001), and tVBO (OR 0.33; 95% CI 0.11-0.86; P=0.031) were significant predictors of 90-day favorable outcome. Conclusion: tVBO was associated with poor outcomes. Further efforts should be aimed at improving outcomes for this subpopulation.
peripheral vascular disease,clinical neurology